The impact of alpha lipoic acid administration on oxidative stress markers and occurrence of no-reflow phenomenon in post myocardial infarction patients
Abstract Background Primary percutaneous coronary intervention (PPCI) is the treatment of choice for ST-segment-elevation myocardial infarction (STEMI). Post-PCI induced-oxidative stress, a complication of PCI, is linked to the no-reflow (NR) phenomenon and poor prognosis. A clinical trial involving...
Saved in:
| Main Authors: | Omar R. Elsayed, Lamia Mohamed El Wakeel, Mohamed Ayman Saleh, Marwa Adel Ahmed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | Future Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43094-025-00805-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No-reflow phenomenon and reperfusion injury. Mechanisms and treatment
by: M. Yu. Gilyarov, et al.
Published: (2022-03-01) -
NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01) -
PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01) -
Estimation of pharmacokinetic parameters of alpha-lipoic acid in the chicks model
by: Marwa R. Abdulghani, et al.
Published: (2022-04-01) -
Advances in Pathophysiology and Novel Therapeutic Strategies for Coronary No-Reflow Phenomenon
by: Hubert Borzuta, et al.
Published: (2025-07-01)